297 related articles for article (PubMed ID: 33730212)
21. A Clinicopathological Approach to Odontogenic Cysts: the Role of Cytokeratin 17 and bcl2 Immunohistochemistry in Identifying Odontogenic Keratocysts.
Cserni D; Zombori T; Vörös A; Stájer A; Rimovszki A; Daru K; Baráth Z; Cserni G
Pathol Oncol Res; 2020 Oct; 26(4):2613-2620. PubMed ID: 32632899
[TBL] [Abstract][Full Text] [Related]
22. Clinical, radiographic, pathological and inherited characteristics of odontogenic keratocyst in nevoid basal cell carcinoma syndrome: a study in three Chilean families.
Castillo-Tobar A; Urzúa B; Tirreau V; Donoso F; Pinares J; Cosmelli-Maturana R; Ortega-Pinto A
Oral Radiol; 2023 Jul; 39(3):518-527. PubMed ID: 36436193
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of MMPs 1, 7, and 26 in syndrome and nonsyndrome odontogenic keratocysts.
Cavalcante RB; Pereira KM; Nonaka CF; Nogueira RL; de Souza LB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):99-105. PubMed ID: 18585626
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical Analysis of Dentigerous Cysts and Odontogenic Keratocysts Associated with Impacted Third Molars-A Systematic Review.
Almeida LE; Loyd D; Boettcher D; Kraft O; Zammuto S
Diagnostics (Basel); 2024 Jun; 14(12):. PubMed ID: 38928661
[TBL] [Abstract][Full Text] [Related]
25. PTCH1 alterations are frequent but other genetic alterations are rare in sporadic odontogenic keratocysts.
Qu J; Zhang J; Zhang H; Li X; Hong Y; Zhai J; Wang Y; Chen F; Li T
Oral Dis; 2019 Sep; 25(6):1600-1607. PubMed ID: 31162759
[TBL] [Abstract][Full Text] [Related]
26. [PTCH gene mutations in odontogenic keratocysts].
Yuan JW; Li TJ; Zhong HH; Zhao HS
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jan; 41(1):41-4. PubMed ID: 16620627
[TBL] [Abstract][Full Text] [Related]
27. Epithelial cell proliferation in odontogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions.
Li TJ; Browne RM; Matthews JB
J Oral Pathol Med; 1995 May; 24(5):221-6. PubMed ID: 7542341
[TBL] [Abstract][Full Text] [Related]
28. Cytokeratin expression in the odontogenic keratocyst.
Meara JG; Pilch BZ; Shah SS; Cunningham MJ
J Oral Maxillofac Surg; 2000 Aug; 58(8):862-5; discussion 866. PubMed ID: 10935585
[TBL] [Abstract][Full Text] [Related]
29. Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts.
Kaczmarzyk T; Kisielowski K; Koszowski R; Rynkiewicz M; Gawełek E; Babiuch K; Bednarczyk A; Drozdzowska B
Clin Oral Investig; 2018 Dec; 22(9):3097-3106. PubMed ID: 29508125
[TBL] [Abstract][Full Text] [Related]
30. [Detection of PTCH gene mutations in odontogenic keratocysts by SSCP and DNA sequencing].
Gu XM; Li TJ
Hua Xi Kou Qiang Yi Xue Za Zhi; 2006 Aug; 24(4):293-6. PubMed ID: 16999341
[TBL] [Abstract][Full Text] [Related]
31. Expression of the Sonic Hedgehog receptor "PATCHED" in basal cell carcinomas and odontogenic keratocysts.
Zedan W; Robinson PA; Markham AF; High AS
J Pathol; 2001 Aug; 194(4):473-7. PubMed ID: 11523056
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of the expression of cyclin D1, COX-2, and KI-67 in odontogenic keratocyst vs. ameloblastoma vs. orthokeratinized odontogenic cyst.
Martín-Hernán F; Campo-Trapero J; Cano-Sánchez J; García-Martín R; Martínez-López M; Ballestín-Carcavilla C
Rev Esp Patol; 2022; 55(2):90-95. PubMed ID: 35483774
[TBL] [Abstract][Full Text] [Related]
33. Recurrence of keratocyst in nevoid basal cell carcinoma syndrome: A major diagnostic dilemma for clinicians.
Gupta A; Suvarna S; Khanna G; Sahoo S
J Cancer Res Ther; 2013; 9(3):543-4. PubMed ID: 24126006
[TBL] [Abstract][Full Text] [Related]
34. Histopathological features that predict the recurrence of odontogenic keratocysts.
Cottom HE; Bshena FI; Speight PM; Craig GT; Jones AV
J Oral Pathol Med; 2012 May; 41(5):408-14. PubMed ID: 22085015
[TBL] [Abstract][Full Text] [Related]
35. Peripheral odontogenic keratocyst: Clinicopathological and immunohistochemical characterization.
Lafuente-Ibáñez de Mendoza I; Aguirre-Urizar JM; Villatoro-Ugalde V; Magaña-Quiñones JJ; Lana-Ojeda J; Mosqueda-Taylor A
Oral Dis; 2022 May; 28(4):1198-1206. PubMed ID: 33682271
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers involved in the proliferation of the odontogenic keratocyst, glandular odontogenic cyst and botryoid odontogenic cyst.
Júnior JF; de França GM; da Silva Barros CC; Felix FA; da Silva WR; de Lucena HF; Oliveira CN; Galvão HC
Oral Maxillofac Surg; 2022 Dec; 26(4):655-662. PubMed ID: 35059898
[TBL] [Abstract][Full Text] [Related]
37. The odontogenic keratocyst revisited.
Stoelinga PJW
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1420-1423. PubMed ID: 35277291
[TBL] [Abstract][Full Text] [Related]
38. Effect of the sonic hedgehog inhibitor GDC-0449 on an in vitro isogenic cellular model simulating odontogenic keratocysts.
Zhai J; Zhang H; Zhang J; Zhang R; Hong Y; Qu J; Chen F; Li T
Int J Oral Sci; 2019 Jan; 11(1):4. PubMed ID: 30610186
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical profile of the anti-apoptosis, apoptosis and proliferation markers Bcl-2, caspase-3, p53, and Ki-67 in botryoid odontogenic cysts compared to lateral periodontal cysts and gingival cysts of the adult.
Basile JR; Castle JT; Redman RS
Biotech Histochem; 2021 May; 96(4):263-268. PubMed ID: 32643438
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous Keratocyst With D2-40 Immunoreactivity in Basal Cell Nevus Syndrome.
Goggins CA; Zerah ML; Anatelli F; Norton SA
Am J Dermatopathol; 2021 Sep; 43(9):659-661. PubMed ID: 33606372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
